Literature DB >> 17520180

Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.

Hajime Konno1, Lynne S Taylor.   

Abstract

PURPOSE: To investigate the ability of various polymers to inhibit the crystallization of amorphous felodipine from amorphous molecular dispersions in the presence of absorbed moisture.
METHODS: Spin coated films of felodipine with poly(vinylpyrrolidone) (PVP), hydroxypropylmethylcellulose acetate succinate (HPMCAS) and hydroxypropylmethylcellulose (HPMC) were exposed to different storage relative humidities and nucleation rates were measured using polarized light microscopy. Solid dispersions were further characterized using differential scanning calorimetry, infrared spectroscopy and gravimetric measurement of water vapor sorption.
RESULTS: It was found that the polymer additive reduced nucleation rates whereas absorbed water enhanced the nucleation rate as anticipated. When both polymer and water were present, nucleation rates were reduced relative to those of the pure amorphous drug stored at the same relative humidity, despite the fact that the polymer containing systems absorbed more water. Differences between the stabilizing abilities of the various polymers were observed and these were explained by the variations in the moisture contents of the solid dispersions caused by the different hygroscopicities of the component polymers. No correlations could be drawn between nucleation rates and the glass transition temperature (Tg) of the system. PVP containing solid dispersions appeared to undergo molecular level changes on exposure to moisture which may be indicative of phase separation.
CONCLUSIONS: In conclusion, it was found that for a given storage relative humidity, although the addition of a polymer increases the moisture content of the system relative to that of the pure amorphous drug, the crystallization tendency was still reduced.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520180     DOI: 10.1007/s11095-007-9331-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Moisture-dependent crystallization of amorphous lamotrigine mesylate.

Authors:  E Schmitt; C W Davis; S T Long
Journal:  J Pharm Sci       Date:  1996-11       Impact factor: 3.534

2.  Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.

Authors:  T Matsumoto; G Zografi
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

3.  Stability and several physical properties of amorphous and crystalline form of indomethacin.

Authors:  H Imaizumi; N Nambu; T Nagai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1980-09       Impact factor: 1.645

4.  Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures.

Authors:  L S Taylor; G Zografi
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

5.  Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25.

Authors:  G Van den Mooter; M Wuyts; N Blaton; R Busson; P Grobet; P Augustijns; R Kinget
Journal:  Eur J Pharm Sci       Date:  2001-01       Impact factor: 4.384

6.  Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen.

Authors:  Tamaki Miyazaki; Sumie Yoshioka; Yukio Aso; Shigeo Kojima
Journal:  J Pharm Sci       Date:  2004-11       Impact factor: 3.534

7.  Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions.

Authors:  Fumié Tanno; Yuichi Nishiyama; Hiroyasu Kokubo; Sakaé Obara
Journal:  Drug Dev Ind Pharm       Date:  2004-01       Impact factor: 3.225

8.  Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates.

Authors:  M Yoshioka; B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1995-08       Impact factor: 3.534

9.  Establishment of new preparation method for solid dispersion formulation of tacrolimus.

Authors:  Kazunari Yamashita; Toshiomi Nakate; Kazuto Okimoto; Atsuo Ohike; Yuji Tokunaga; Rinta Ibuki; Kazutaka Higaki; Toshikiro Kimura
Journal:  Int J Pharm       Date:  2003-11-28       Impact factor: 5.875

10.  The relationship between the glass transition temperature and water vapor absorption by poly(vinylpyrrolidone)

Authors:  C A Oksanen; G Zografi
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

View more
  18 in total

1.  Understanding the tendency of amorphous solid dispersions to undergo amorphous-amorphous phase separation in the presence of absorbed moisture.

Authors:  Alfred C F Rumondor; Håkan Wikström; Bernard Van Eerdenbrugh; Lynne S Taylor
Journal:  AAPS PharmSciTech       Date:  2011-09-17       Impact factor: 3.246

Review 2.  Multifunctional Role of Polyvinylpyrrolidone in Pharmaceutical Formulations.

Authors:  Yu Luo; Yanlong Hong; Lan Shen; Fei Wu; Xiao Lin
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

3.  Parts per Million Powder X-ray Diffraction.

Authors:  Justin A Newman; Paul D Schmitt; Scott J Toth; Fengyuan Deng; Shijie Zhang; Garth J Simpson
Journal:  Anal Chem       Date:  2015-10-22       Impact factor: 6.986

4.  Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.

Authors:  Emad B Basalious; Wessam El-Sebaie; Omaima El-Gazayerly
Journal:  AAPS PharmSciTech       Date:  2011-06-24       Impact factor: 3.246

5.  Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.

Authors:  Nivedita Shetty; Patricia Ahn; Heejun Park; Sonal Bhujbal; Dmitry Zemlyanov; Alex Cavallaro; Sharad Mangal; Jian Li; Qi Tony Zhou
Journal:  Mol Pharm       Date:  2018-08-03       Impact factor: 4.939

6.  In vitro characterization of a novel polymeric system for preparation of amorphous solid drug dispersions.

Authors:  Zahra N Mahmoudi; Sampada B Upadhye; David Ferrizzi; Ali R Rajabi-Siahboomi
Journal:  AAPS J       Date:  2014-05-02       Impact factor: 4.009

7.  ToF-SIMS analysis of chemical heterogenities in inkjet micro-array printed drug/polymer formulations.

Authors:  Nikolaos Scoutaris; Andrew L Hook; Paul R Gellert; Clive J Roberts; Morgan R Alexander; David J Scurr
Journal:  J Mater Sci Mater Med       Date:  2011-11-16       Impact factor: 3.896

Review 8.  Second-order nonlinear optical imaging of chiral crystals.

Authors:  David J Kissick; Debbie Wanapun; Garth J Simpson
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2011       Impact factor: 10.745

9.  Physico-Mechanical Properties of Coprocessed Excipient MicroceLac® 100 by DM(3) Approach.

Authors:  Rahul V Haware; Joseph P Kancharla; Aishwarya K Udupa; Scott Staton; Mali R Gupta; Antoine Al-Achi; William C Stagner
Journal:  Pharm Res       Date:  2015-06-09       Impact factor: 4.200

10.  Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.

Authors:  Alfred C F Rumondor; Lindsay A Stanford; Lynne S Taylor
Journal:  Pharm Res       Date:  2009-10-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.